Angiotensin I Converting Enzyme (ACE-2), also called ACEH (ACE homologue), is a dimeric, zinc-dependent metalloprotease of the ACE family that also includes somatic and germinal ACE. ACE-2 mRNA is found at high levels in heart, testis, and kidney and at lower levels in a wide variety of tissues. ACE-2 is the SARS-CoV and SARS-CoV2 Spike protein receptor in vivo, functions catalytically as a carboxypeptidase to cleave several substrates including angiotensins I and II, and acts as a partner for B0AT1-family amino acid transporters. Through these functions, ACE-2 has been shown to be involved in several diseases including SARS, COVID19, acute lung injury, heart disease, liver and lung fibrosis, inflammatory lung disease, and cardiopulmonary disease . Full length ACE-2 protein includes an extracellular region composed of a single N-terminal peptidase domain and C-terminal collectrin-like domain (CLD), a transmembrane domain, and a short cytoplasmic tail. The N-terminal peptidase region is required for binding to SARS-CoV and SARS-CoV2 spike proteins, while the CLD contains a region that promotes dimerization and association with amino acid transporters.FGF-18與FGF R2C,F(xiàn)GF R3C以及高爾基蛋白GLG1結(jié)合,并誘導星形膠質(zhì)細胞和小膠質(zhì)細胞。Recombinant Human CEACAM-3 Protein,His Tag
3C蛋白酶是切割小RNA病毒科非結(jié)構(gòu)蛋白的關(guān)鍵酶,在病毒復制過程中發(fā)揮著重要作用。鼻病毒屬于小RNA病毒科,其中的人鼻病毒3C蛋白酶基因編碼區(qū)全長552bp,編碼的蛋白質(zhì)相對分子質(zhì)量約為22000Da。人鼻病毒3C蛋白酶具有高度的酶切特異性,能特異切割位于Gln-Gly之間的肽鍵,識別位點為Leu-Glu-Val-Leu-Phe-Gln↓Gly-Pro。本公司將人鼻病毒3C蛋白酶的編碼區(qū)基因,在大腸桿菌中進行重組表達,純化后獲得了高純度的重組3C蛋白酶,該蛋白酶能特異切割含有3C酶切位點的融合蛋白,具有良好的生物學活性。同時,本公司生產(chǎn)的3C蛋白酶帶有GST和MAT標簽蛋白,有利于后期將其從酶切體系中去除。產(chǎn)品性質(zhì):中文別名(Chinesesynonym):3C蛋白酶英文別名(Englishsynonym):3CProtease來源(Source):大腸桿菌表達標簽(label):GST-3CProtease-MAT純度(Purity):經(jīng)SDS-PAGE及HPLC分析,純度>95%分子量(Molecularweight):47.38kDa比活性(Specificactivity):500U/ml緩沖液組分(Buffer):50mMTris-HCl,150mMNaCl,1mMEDTA,1mMDTT,pH7.0酶活定義(UnitDefinition):在緩沖液中切割100μg被檢測的融合蛋白,反應條件為4℃16小時,切割率≥90%運輸和保存方法:干冰運輸;保存于-20℃。Recombinant Human HPN Protein,His Tag然而,在肝臟中,IL-28A誘導的Th1細胞因子反應有助于T細胞介導的肝炎的炎癥。
Recombinant Biotinylated Human MSLN/Mesothelin Protein,hFc-Avi Tag分子別名(Synonyms)Mesothelin;CAK1;MSLN;MPFSMRP表達區(qū)間及表達系統(tǒng)(Source)BiotinylatedHumanMSLN/MesothelinProteinisexpressedfromHEK293withhFctagandAvitagattheC-Terminus.ItcontainsGlu296-Gly580.[Accession|Q13421-2]分子量大小(MolecularWeight)TheproteinhasapredictedMWof61.1kDa.Duetoglycosylation,theproteinmigratesto70-80kDabasedonSDS-PAGEresult.(Endotoxin)Lessthan1EUperμgbytheLALmethod.純度(Purity)>95%asdeterminedbySDS-PAGEandHPLC.活性(Activity)ELISAData:ImmobilizedAnti-MSLNAntibody,hFcTagat1μg/ml(100μl/well)ontheplate.DoseresponsecurveforBiotinylatedHumanMSLN,hFcTagwiththeEC50of18.4ng/mldeterminedbyELISA.
α-凝血酶(α-Thrombin)是一種高度特異性的絲氨酸蛋白酶,由凝血酶原(Prothrombin,II因子)經(jīng)蛋白水解活化而來。它在凝血過程中起著非常重要的作用,不僅能夠促使纖維蛋白凝塊的產(chǎn)生,還負責提供反饋信號來尋找前輔因子:V因子和VIII因子。也可以用作血管收縮劑。在體內(nèi),活化的X因子(FactorXa)切割凝血酶原,釋放出活性肽并將凝血酶切割成具有催化活性的α-凝血酶。α-凝血酶由一條輕鏈(Achain)(Mw~6,000)和一條重鏈(Bchain)(Mw~31,000)通過二硫鍵連接而成。某些情況下,α-凝血酶會發(fā)生自溶生成β-凝血酶和γ-凝血酶。β-凝血酶由對α-凝血酶A鏈水解并切割含有B鏈糖基化位點的小片段(B1,B2)組合而成。除了用于凝血研究之外,α-凝血酶還常用來位點特異性切割融合蛋白?;蛑亟M時將凝血酶識別位點插入在目的蛋白與利于后續(xù)純化和/或表達的多肽或者蛋白之間,通過凝血酶切割表達的重組子即可釋放目的蛋白。凝血酶本身可通過親和層析技術(shù)快速去除。本品是由勻質(zhì)化的人凝血酶原經(jīng)由Xa因子,Va因子和磷脂活化而得,經(jīng)SDS-PAGE檢測確保凝血酶原的完全活化,并以NIH凝血酶的標準品為參考,提供的酶活力不少于3091NIHU/mg。(CDNF)也是一種新型神經(jīng)營養(yǎng)因子,對多巴胺能神經(jīng)元的強大活性,與神經(jīng)膠質(zhì)細胞系衍生的(GDNF)相當。
N-糖苷酶F(PNGaseF)是一種酰胺水解酶,經(jīng)過和平空間站伊麗莎菌克隆,主要由腦膜炎膿桿菌等革蘭氏陰性菌分泌。酵母重組表達N-糖苷酶F(比活性:750000U/mL),可以裂解由天冬酰胺連接的高甘露糖、雜合和復雜的寡糖糖蛋白。PNGaseF的切割位點為糖蛋白內(nèi)側(cè)N-乙酰葡萄糖胺(GlcNAc)和天冬酰氨殘基之間的酰胺鍵,同時將酶解后蛋白上的天冬氨酰轉(zhuǎn)化為天冬氨酸。本產(chǎn)品帶his標簽,常應用于抗體及其相關(guān)蛋白完全去糖基化。另外,我司還提供其他類型的糖苷酶,包括酵母重組表達的N-糖苷酶F,糖苷內(nèi)切酶H,糖苷內(nèi)切酶S。產(chǎn)品信息產(chǎn)品性質(zhì)中文別名(Chinesesynonym)N-糖酰胺酶F;N-糖苷酶F英文別名(Englishsynonym)PNGaseF來源(Source)酵母重組表達分子量(Molecularweight)36kDa比活性(Specificactivity)750000U/mL緩沖液組分(Buffer)20mMTris-HClpH7.5,50mMNaCl,5mMEDTA,50%Glycerollag-1是通過CCR5受體發(fā)出信號的CC趨化因子。 LAG-1與MIP-1β(ACT II同種型)相同,但兩個氨基酸取代。Recombinant Cynomolgus IGFBP2 Protein,His Tag
IdeS Protease全稱免疫球蛋白G降解酶是由人類致病菌釀膿鏈球菌產(chǎn)生并分泌至胞外的一種半胱氨酸水解酶。Recombinant Human CEACAM-3 Protein,His Tag
Trop-2,alsoknownasepithelialglycoprotein-1antigen(EGP-1),isaproteinthatinhumansisencodedbytheTACSTD2gene.Mutationsofthisgeneresultingelatinousdrop-likecornealdystrophy,anautosomalrecessivedisordercharacterizedbyseverecornealamyloidosisleadingtoblindness.產(chǎn)品性質(zhì)別名EGP1;EGP-1;TROP2;GA733-1;gp50;T16;TACSTD2;TROP-2;M1S1;TACD2UniprotNo.P09758表達區(qū)間及表達系統(tǒng)RecombinantBiotinylatedHumanTROP-2/TACSTD2ProteinisexpressedfromHEK293cellswithHistagandAvitagattheC-terminal.ItcontainsHis27-Thr274.分子量TheproteinhasapredictedMWof30.5kDa.Duetoglycosylation,theproteinmigratesto46-55kDabasedonTris-BisPAGEresult.純度>95%asdeterminedbySDS-PAGEandHPLC活性ELISAData:ImmobilizedAnti-TROP-2Antibody,hFcTagat0.5μg/mL(100μL/well)ontheplate.DoseresponsecurveforBiotinylatedHumanTROP-2,HisTagwiththeEC50of24.1ng/mLdeterminedbyELISA.0EUper1μgoftheproteinbytheLALmethod.制劑Lyophilizedfrom0.22μmfilteredsolutioninPBS(pH7.4).Normally5%trehaloseisaddedasprotectantbeforelyophilization.Recombinant Human CEACAM-3 Protein,His Tag
浦斯瑞(上海)生物醫(yī)藥有限公司是一家有著雄厚實力背景、信譽可靠、勵精圖治、展望未來、有夢想有目標,有組織有體系的公司,堅持于帶領(lǐng)員工在未來的道路上大放光明,攜手共畫藍圖,在江蘇省等地區(qū)的化工行業(yè)中積累了大批忠誠的客戶粉絲源,也收獲了良好的用戶口碑,為公司的發(fā)展奠定的良好的行業(yè)基礎,也希望未來公司能成為*****,努力為行業(yè)領(lǐng)域的發(fā)展奉獻出自己的一份力量,我們相信精益求精的工作態(tài)度和不斷的完善創(chuàng)新理念以及自強不息,斗志昂揚的的企業(yè)精神將**浦斯瑞(上海)生物醫(yī)藥供應和您一起攜手步入輝煌,共創(chuàng)佳績,一直以來,公司貫徹執(zhí)行科學管理、創(chuàng)新發(fā)展、誠實守信的方針,員工精誠努力,協(xié)同奮取,以品質(zhì)、服務來贏得市場,我們一直在路上!